Literature DB >> 1100712

Experimental model of oral antityphoid vaccination with live streptomycin-dependent Salmonella typhimurium in C57BL/6 mice.

I R Vladoianu, F Dubini.   

Abstract

The present experimental model offered the opportunity to study particular aspects concerning the avirulence stability of live streptomycin-dependent (Sm D) Salmonella vaccines, under conditions resembling human enteric fever. The results seem to indicate that, in practice, the risk of reversion to a virulent form during oral antityphoid vaccination with Sm D strains remains slight even after the interruption of concomitant streptomycin administration.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1100712      PMCID: PMC2130300          DOI: 10.1017/s0022172400047240

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  4 in total

1.  Immunization studies with living vaccine of Salmonella typhimurium.

Authors:  L S BARON; S B FORMAL
Journal:  Proc Soc Exp Biol Med       Date:  1960 Aug-Sep

2.  Immunity in typhoid fever: evaluation of live streptomycin-dependent vaccine.

Authors:  H L DuPont; R B Hornick; M J Snyder; J P Libonati; T E Woodward
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

3.  Contribution to the study of live streptomycin-dependent Salmonella vaccines: the problem of reversion to a virulent form.

Authors:  I R Vladoianu; F Dubini; A Bolloli
Journal:  J Hyg (Lond)       Date:  1975-10

4.  Salmonellosis in orally infected specific pathogen-free C57B1 mice.

Authors:  F M Collins
Journal:  Infect Immun       Date:  1972-02       Impact factor: 3.441

  4 in total
  1 in total

1.  Salmonella Typhimurium TTSS-2 deficient mig-14 mutant shows attenuation in immunocompromised mice and offers protection against wild-type Salmonella Typhimurium infection.

Authors:  Niladri Bhusan Pati; Vikalp Vishwakarma; Sathish Kumar Selvaraj; Sabyasachi Dash; Bhaskar Saha; Neera Singh; Mrutyunjay Suar
Journal:  BMC Microbiol       Date:  2013-10-22       Impact factor: 3.605

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.